Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus. The investigators next plan to test the vaccine in nonhuman primates and humans to see if it is safe and effective in preventing COVID-19 infection.
- Boys’ club barriers create issues for Australian boards
- Controlling ultrastrong light-matter coupling at room temperature
- Inside the secret lives of synchronous fireflies
- KIST develops ambient vibration energy harvester with automatic resonance tuning mechanism
- Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death